Cargando…

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma

Because of its multifactorial nature, predicting the presence of cancer using a single biomarker is difficult. We aimed to establish a novel machine-learning model for predicting hepatocellular carcinoma (HCC) using real-world data obtained during clinical practice. To establish a predictive model,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masaya, Morimoto, Kentaro, Kajihara, Shigeki, Tateishi, Ryosuke, Shiina, Shuichiro, Koike, Kazuhiko, Yatomi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543030/ https://www.ncbi.nlm.nih.gov/pubmed/31147560 http://dx.doi.org/10.1038/s41598-019-44022-8

Ejemplares similares

In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database
por: Sato, Masaya, et al.
Publicado: (2019)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
por: Fujiwara, Naoto, et al.
Publicado: (2013)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
por: Shiina, Shuichiro, et al.
Publicado: (2018)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Utility of hepatic vein waveform and transient elastography in patients with Budd–Chiari syndrome who require angioplasty: Two case reports
por: Nakatsuka, Takuma, et al.
Publicado: (2019)

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
por: Ikeda, Masafumi, et al.
Publicado: (2014)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Association between hospital volume and in‐hospital mortality following radiofrequency ablation for hepatocellular carcinoma
por: Sato, M., et al.
Publicado: (2017)

Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
por: Enooku, Kenichiro, et al.
Publicado: (2016)

Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
por: Nakagomi, Ryo, et al.
Publicado: (2021)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma
por: Uranbileg, Baasanjav, et al.
Publicado: (2020)

Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)
por: Mikoshiba, Naoko, et al.
Publicado: (2012)

Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor
por: Shinohara, Kentaro, et al.
Publicado: (2017)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Development and prognosis of hepatocellular carcinoma in patients with diabetes
por: Nakatsuka, Takuma, et al.
Publicado: (2023)

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
por: Tateishi, Ryosuke, et al.
Publicado: (2014)

Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis
por: Sato, Masaya, et al.
Publicado: (2014)

A case of simultaneous abdominal wall metastasis of hepatocellular carcinoma with long-term relapse-free survival after laparoscopic resection
por: Goto, Michitoshi, et al.
Publicado: (2021)

Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method
por: Zhang, Zi-Mei, et al.
Publicado: (2020)

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Machine-Learning Studies on Spin Models
por: Shiina, Kenta, et al.
Publicado: (2020)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma
por: Okubo, Hironao, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database
por: Okushin, Kazuya, et al.
Publicado: (2023)

Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis
por: Okubo, Hironao, et al.
Publicado: (2021)

A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
por: Tateishi, Ryosuke, et al.
Publicado: (2018)

Development of pancreatic cancer during observation for hepatocellular carcinoma: A retrospective cohort study
por: Gonoi, Wataru, et al.
Publicado: (2019)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f2qvhosgd3ri2d31ht3vh3f4ce